Showing results (311-320 of 482) with videos related to

Sort By:
Pageof 49
Disease Models & Mechanisms|January 31, 2015
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancerCameron N Johnstone, Yvonne E Smith, Yuan Cao, et al.
Molecular Cell|August 11, 2023
PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostateTamara A M Chessa, Piotr Jung, Arqum Anwar, et al.
Nature Cell Biology|November 9, 2021
The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 functionKatarzyna Koltowska, Kazuhide S Okuda, Marleen Gloger, et al.
Cancer Discovery|January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysisTiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Plos One|May 3, 2011
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancersÅslaug Helland, Michael S Anglesio, Joshy George, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Science Signaling|October 2, 2014
Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regenerationToby J Phesse, Michael Buchert, Emma Stuart, et al.
Wellcome Open Research|May 24, 2024
Improving modelling for epidemic responses: reflections from members of the UK infectious disease modelling community on their experiences during the COVID-19 pandemicKatharine Sherratt, Anna C Carnegie, Adam Kucharski, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Pageof 49